These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
395 related articles for article (PubMed ID: 19636983)
21. Design and Feasibility of an Intervention to Support Cancer Genetic Counselees in Informing their At-Risk Relatives. de Geus E; Eijzenga W; Menko FH; Sijmons RH; de Haes HC; Aalfs CM; Smets EM J Genet Couns; 2016 Dec; 25(6):1179-1187. PubMed ID: 27103421 [TBL] [Abstract][Full Text] [Related]
22. Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors. Bober SL; Hoke LA; Duda RB; Regan MM; Tung NM J Clin Oncol; 2004 Dec; 22(24):4951-7. PubMed ID: 15598980 [TBL] [Abstract][Full Text] [Related]
23. Development of the breast cancer education and risk assessment program. Snyder LA; Soballe DB; Lahl LL; Nehrebecky ME; Soballe PW; Klein PM Oncol Nurs Forum; 2003; 30(5):803-8. PubMed ID: 12949593 [TBL] [Abstract][Full Text] [Related]
24. A detailed description of mothers' knowledge before genetic counseling for Down syndrome: Part I. Antley RM; Seidenfeld MJ Am J Med Genet; 1978; 2(4):357-64. PubMed ID: 162526 [TBL] [Abstract][Full Text] [Related]
25. Nonverbal communication and conversational contribution in breast cancer genetic counseling: are counselors' nonverbal communication and conversational contribution associated with counselees' satisfaction, needs fulfillment and state anxiety in breast cancer genetic counseling? Dijkstra H; Albada A; Klöckner Cronauer C; Ausems MG; van Dulmen S Patient Educ Couns; 2013 Nov; 93(2):216-23. PubMed ID: 23786807 [TBL] [Abstract][Full Text] [Related]
26. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. American Society of Clinical Oncology J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171 [TBL] [Abstract][Full Text] [Related]
27. Risk perception among women receiving genetic counseling: a population-based follow-up study. Mikkelsen EM; Sunde L; Johansen C; Johnsen SP Cancer Detect Prev; 2007; 31(6):457-64. PubMed ID: 18061369 [TBL] [Abstract][Full Text] [Related]
28. The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer. Watson M; Lloyd S; Davidson J; Meyer L; Eeles R; Ebbs S; Murday V Br J Cancer; 1999 Feb; 79(5-6):868-74. PubMed ID: 10070883 [TBL] [Abstract][Full Text] [Related]
29. Longer-term influence of breast cancer genetic counseling on cognitions and distress: smaller benefits for affected versus unaffected women. Pieterse AH; Ausems MG; Spreeuwenberg P; van Dulmen S Patient Educ Couns; 2011 Dec; 85(3):425-31. PubMed ID: 21316181 [TBL] [Abstract][Full Text] [Related]
30. Genetic counseling does not fulfill the counselees' need for certainty in hereditary breast/ovarian cancer families: an explorative assessment. Vos J; Menko FH; Oosterwijk JC; van Asperen CJ; Stiggelbout AM; Tibben A Psychooncology; 2013 May; 22(5):1167-76. PubMed ID: 22777929 [TBL] [Abstract][Full Text] [Related]
31. Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer. Tiller K; Meiser B; Gould L; Tucker K; Dudding T; Franklin J; Friedlander M; Andrews L Psychooncology; 2005 Apr; 14(4):249-61. PubMed ID: 15386771 [TBL] [Abstract][Full Text] [Related]
32. Counselees' Expressed Level of Understanding of the Risk Estimate and Surveillance Recommendation are Not Associated with Breast Cancer Surveillance Adherence. Albada A; van Dulmen S; Dijkstra H; Wieffer I; Witkamp A; Ausems MG J Genet Couns; 2016 Apr; 25(2):279-89. PubMed ID: 26321750 [TBL] [Abstract][Full Text] [Related]
33. Effect on perceived control and psychological distress of genetic knowledge in women with breast cancer receiving a BRCA1/2 test result. Brédart A; Kop JL; De Pauw A; Caron O; Fajac A; Noguès C; Stoppa-Lyonnet D; Dolbeault S Breast; 2017 Feb; 31():121-127. PubMed ID: 27837705 [TBL] [Abstract][Full Text] [Related]
34. Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information. DiCastro M; Frydman M; Friedman I; Shiri-Sverdlov R; Papa MZ; Goldman B; Friedman E Am J Med Genet; 2002 Aug; 111(2):147-51. PubMed ID: 12210341 [TBL] [Abstract][Full Text] [Related]
35. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011 [TBL] [Abstract][Full Text] [Related]
36. Genetic counseling: a comparison of counselee's genetic knowledge before and after (Part III). Seidenfeld MJ; Antley RM Am J Med Genet; 1981; 10(2):107-12. PubMed ID: 6459029 [TBL] [Abstract][Full Text] [Related]
37. A literature review of the psychological impact of genetic testing on breast cancer patients. Schlich-Bakker KJ; ten Kroode HF; Ausems MG Patient Educ Couns; 2006 Jul; 62(1):13-20. PubMed ID: 16242293 [TBL] [Abstract][Full Text] [Related]
38. Psychosocial impact of the lack of information given at referral about familial risk for cancer. Metcalfe A; Werrett J; Burgess L; Clifford C Psychooncology; 2007 May; 16(5):458-65. PubMed ID: 16933207 [TBL] [Abstract][Full Text] [Related]
39. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey. Di Prospero LS; Seminsky M; Honeyford J; Doan B; Franssen E; Meschino W; Chart P; Warner E CMAJ; 2001 Apr; 164(7):1005-9. PubMed ID: 11314429 [TBL] [Abstract][Full Text] [Related]
40. Patients' resistance to risk information in genetic counseling for BRCA1/2. Gurmankin AD; Domchek S; Stopfer J; Fels C; Armstrong K Arch Intern Med; 2005 Mar; 165(5):523-9. PubMed ID: 15767527 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]